Global BioAccess Fund partners with companies to invest in transformative technologies addressing unmet needs in oncology, cardiovascular, CNS, and rare diseases. The fund invests in companies developing novel therapeutics and devices for serious unmet medical needs, focusing on early-stage companies needing capital for IND submission and clinical trials.

Global BioAccess Fund

At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.

Congratulations to Acesion Pharma on their publication in Nature Medicine and launching their Ph 1 trial!

We look forward to working with the Odyssey team and Board as they move multiple programs into the clinic.
https://lnkd.in/eWzTVQxh

We are thrilled to be working with Acesion Pharma, Canaan, Alpha Wave Global, LP and Novo Holdings to bring safer and more effective treatments to patients with atrial fibrillation.

https://lnkd.in/e2XDz4zX

Metric
Company Name	Global BioAccess Fund
Symbol
MSH ID	COM:GLOBALBIOACCESS
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital & Private Equity
Country	US
Stage
Employee Count	7
Website	globalbioaccess.com
LinkedIn	global-bioaccess-fund
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	293
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GLOB

COM:GLOBALBIOACCESS

Global BioAccess Fund

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue